Articles with "ccl22" as a keyword



Photo from wikipedia

CCL22 signaling contributes to sorafenib resistance in hepatitis B virus-associated hepatocellular carcinoma.

Sign Up to like & get
recommendations!
Published in 2020 at "Pharmacological research"

DOI: 10.1016/j.phrs.2020.104800

Abstract: The HBV-initiated hepatocellular carcinoma (HCC) frequently develops from or accompanies long-term chronic hepatitis, inflammation, and cirrhosis, and has a poor prognosis. Sorafenib, an orally active multi-kinase inhibitor, currently the most common approved drug for first-line… read more here.

Keywords: hepatocellular carcinoma; ccl22 signaling; ccl22; sorafenib resistance ... See more keywords
Photo by charlesdeluvio from unsplash

circ_0004140 promotes LUAD tumor progression and immune resistance through circ_0004140/miR-1184/CCL22 axis

Sign Up to like & get
recommendations!
Published in 2022 at "Cell Death Discovery"

DOI: 10.1038/s41420-022-00983-w

Abstract: Lung adenocarcinoma (LUAD) is a highly prevalent cancer with high mortality. Immune resistance and tumor metastasis are the pivotal factors for the promotion of LUAD. CircRNAs have been revealed a crucial pre-clinical diagnostic and therapeutic… read more here.

Keywords: circ 0004140; immune resistance; resistance; mir 1184 ... See more keywords
Photo from wikipedia

MicroRNA-15a/16-1 Prevents Hepatocellular Carcinoma by Disrupting the Communication between Kupffer Cells and Tregs.

Sign Up to like & get
recommendations!
Published in 2021 at "Gastroenterology"

DOI: 10.1053/j.gastro.2021.10.015

Abstract: BACKGROUND & AIMS Hepatocellular carcinoma (HCC) is characterized by intratumoral accumulation of regulatory T-cells (Tregs), which suppresses antitumor immunity. This study was designed to investigate how microRNAs regulate immunosuppression in HCC. METHODS FVB/NJ mice were… read more here.

Keywords: ras myc; akt ras; hepatocellular carcinoma; hcc ... See more keywords
Photo from wikipedia

Abstract 5020: Therapeutic potential of an immune modulatory CCL22-based vaccine

Sign Up to like & get
recommendations!
Published in 2019 at "Immunology"

DOI: 10.1158/1538-7445.am2019-5020

Abstract: CCL22 is a macrophage-derived chemokine that exerts immunosuppressive functions by the recruitment of regulatory T cells (Tregs) through the CCL22/CCR4 axis. It is expressed by cells in the tumor microenvironment (TME) in many different cancer… read more here.

Keywords: immune modulatory; cancer; tumor; ccl22 specific ... See more keywords
Photo by nci from unsplash

Abstract 5153: The role of CCL22-specific CD4 T cells in modulating the immunosuppressive tumor microenvironment in ovarian cancer

Sign Up to like & get
recommendations!
Published in 2023 at "Cancer Research"

DOI: 10.1158/1538-7445.am2023-5153

Abstract: Background: CCL22, a macrophage-derived chemokine, is overexpressed in ovarian cancer and exerts immunosuppressive functions by the recruitment of regulatory T cells (Tregs) to the tumor microenvironment (TME). Our research group described naturally occurring T cells… read more here.

Keywords: ccl22 specific; ovarian cancer; ccl22; specific cd4 ... See more keywords
Photo from wikipedia

Recurrent Mutations of the C-C Motif Chemokine Ligand 22 (CCL22) Define a Distinct Subgroup of Chronic Lymphoproliferative Disorder of NK Cells (CLPD-NK)

Sign Up to like & get
recommendations!
Published in 2020 at "Blood"

DOI: 10.1182/blood-2020-140695

Abstract: Background: The pathogenesis of chronic lymphoproliferative disorder of NK-cells (CLPD-NK) is poorly understood. Mutations in the JAK/STAT pathway (especially STAT3) are found in 30% of patients, but the genetic or exogenous drivers responsible for other… read more here.

Keywords: expression; entity board; membership entity; mtccl22 ... See more keywords
Photo by nci from unsplash

LncRNA HOTAIR promotes proliferation, invasion and migration in NSCLC cells via the CCL22 signaling pathway

Sign Up to like & get
recommendations!
Published in 2022 at "PLoS ONE"

DOI: 10.1371/journal.pone.0263997

Abstract: Long noncoding RNA (LncRNA) is a new type of regulatory RNA. LncRNA HOX antisense intergenic RNA (HOTAIR), as an oncogene in non-small cell lung cancer (NSCLC), is one of the key determinants of tumor progression.… read more here.

Keywords: cell; lncrna hotair; ccl22; hotair ... See more keywords
Photo from wikipedia

M2 macrophages confer resistance to 5-fluorouracil in colorectal cancer through the activation of CCL22/PI3K/AKT signaling

Sign Up to like & get
recommendations!
Published in 2019 at "OncoTargets and therapy"

DOI: 10.2147/ott.s198126

Abstract: Background: M2 macrophages are crucial components of tumor microenvironment that frequently associated with the resistance of therapeutic treatments in human cancers, but their role in the chemosensitivity of colorectal cancer (CRC) to 5-fluorouracil (5-FU) is… read more here.

Keywords: resistance; crc; colorectal cancer; pi3k akt ... See more keywords

CCL22-Producing Resident Macrophages Enhance T Cell Response in Sjögren's Syndrome

Sign Up to like & get
recommendations!
Published in 2018 at "Frontiers in Immunology"

DOI: 10.3389/fimmu.2018.02594

Abstract: Macrophages (MΦs) are critical regulators of immune response and serve as a link between innate and acquired immunity. The precise mechanism of involvement of tissue-resident MΦs in the pathogenesis of autoimmune diseases is not clear.… read more here.

Keywords: gren syndrome; ccl22; cell response; tissue ... See more keywords
Photo from wikipedia

Bexarotene Reduces Production of CCL22 From Tumor-Associated Macrophages in Cutaneous T-Cell Lymphoma

Sign Up to like & get
recommendations!
Published in 2019 at "Frontiers in Oncology"

DOI: 10.3389/fonc.2019.00907

Abstract: Bexarotene is a third-generation retinoid X receptor-selective retinoid that has been approved for use in the treatment of both early and advanced cutaneous T-cell lymphoma (CTCL). Although bexarotene has been used for decades in the… read more here.

Keywords: tumor; ccl22; production ccl22; bexarotene ... See more keywords
Photo from wikipedia

Higher CCL22+ Cell Infiltration is Associated with Poor Prognosis in Cervical Cancer Patients

Sign Up to like & get
recommendations!
Published in 2019 at "Cancers"

DOI: 10.3390/cancers11122004

Abstract: The chemokine CCL22 recruits regulatory T (T-reg) cells into tumor tissues and is expressed in many human tumors. However, the prognostic role of CCL22 in cervical cancer (CC) has not been determined. This study retrospectively… read more here.

Keywords: ccl22; group; cervical cancer; cancer ... See more keywords